Valsalva maneuver
The Valsalva maneuver is a common medical procedure often employed in both diagnostic and therapeutic settings. It's named after the 17th-century Italian anatomist Antonio Maria Valsalva, who first described its utility in the examination of the ear.
Description
The Valsalva maneuver is performed by moderately forceful attempted exhalation against a closed airway, usually done by closing one's mouth, pinching one's nose shut while expelling air out as if blowing up a balloon.<ref>,
The Valsalva manoeuvre: a critical review, Heart, Vol. 101(Issue: 18), pp. 1446–1451, DOI: 10.1136/heartjnl-2015-307541, PMID: 26109559,</ref>
Medical Uses
Diagnostic
The maneuver can be used in a medical examination as a test of cardiac function and autonomic nervous control of the heart.<ref>,
The Valsalva manoeuvre: a critical review, Heart, Vol. 101(Issue: 18), pp. 1446–1451, DOI: 10.1136/heartjnl-2015-307541, PMID: 26109559,</ref> Variations of the maneuver can be used to diagnose conditions such as orthostatic hypotension and POTS.
Therapeutic
In addition to its diagnostic uses, the Valsalva maneuver can also be used therapeutically to clear the ears and sinuses (that is, to equalize pressure between them) when ambient pressure changes, such as in scuba diving, hyperbaric oxygen therapy, or air travel.<ref>,
The Valsalva manoeuvre: a critical review, Heart, Vol. 101(Issue: 18), pp. 1446–1451, DOI: 10.1136/heartjnl-2015-307541, PMID: 26109559,</ref> It can also be used to terminate supraventricular tachycardia (SVT), a rapid heart rhythm originating at or above the atrioventricular node.
Procedure
During the Valsalva maneuver, individuals are typically asked to take a deep breath and then forcibly exhale against a closed airway. This can be achieved by closing the mouth and pinching the nose shut while "bearing down" or attempting to exhale. This causes various physiologic changes, including increased intrathoracic pressure, decreased venous return to the heart, and, ultimately, changes in heart rate and blood pressure.
Risks
Despite its benefits, the Valsalva maneuver is not without risks. It can potentially lead to the development of barotrauma, particularly in those with underlying lung disease. It should be used with caution in individuals with cardiovascular disease, as the changes in heart rate and blood pressure can potentially exacerbate these conditions.<ref>,
The Valsalva manoeuvre: a critical review, Heart, Vol. 101(Issue: 18), pp. 1446–1451, DOI: 10.1136/heartjnl-2015-307541, PMID: 26109559,</ref>
Physiology
The Valsalva maneuver consists of four distinct phases, each with its own physiological response.<ref>,
The Valsalva manoeuvre: a critical review, Heart, Vol. 101(Issue: 18), pp. 1446–1451, DOI: 10.1136/heartjnl-2015-307541, PMID: 26109559,</ref>
Phase One
The onset of the maneuver where intrathoracic pressure increases, causing a brief rise in blood pressure due to compression of the aorta.
Phase Two
The pressure continues to build up within the thoracic cavity, leading to a decrease in venous return to the heart and subsequently a drop in cardiac output and blood pressure. The body compensates by increasing the heart rate and constricting peripheral blood vessels to maintain blood flow to vital organs.
Phase Three
This phase begins when the individual stops straining, leading to a sudden drop in intrathoracic pressure. This briefly leads to further decreased blood pressure.
Phase Four
The final phase is characterized by a rapid increase in cardiac output and blood pressure. This is due to the sudden increase in venous return to the heart following the release of intrathoracic pressure. The body responds by decreasing the heart rate to prevent a sudden surge in blood pressure.
See Also
References
<references />
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


